PHIA Stock Overview
Operates as a health technology company in North America, the Greater China, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Koninklijke Philips N.V. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €27.24 |
| 52 Week High | €28.14 |
| 52 Week Low | €15.94 |
| Beta | 0.72 |
| 11 Month Change | 3.57% |
| 3 Month Change | 10.96% |
| 1 Year Change | 41.78% |
| 33 Year Change | -26.05% |
| 5 Year Change | -31.20% |
| Change since IPO | 2,333.60% |
Recent News & Updates
Recent updates
Koninklijke Philips N.V. Just Missed EPS By 19%: Here's What Analysts Think Will Happen Next
Jul 31
Improved Revenues Required Before Koninklijke Philips N.V. (AMS:PHIA) Shares Find Their Feet
Jul 29These 4 Measures Indicate That Koninklijke Philips (AMS:PHIA) Is Using Debt Extensively
Jun 23Here's Why Koninklijke Philips (AMS:PHIA) Has A Meaningful Debt Burden
Mar 21Lacklustre Performance Is Driving Koninklijke Philips N.V.'s (AMS:PHIA) Low P/S
Jan 21Does Koninklijke Philips (AMS:PHIA) Have A Healthy Balance Sheet?
Dec 16Koninklijke Philips (AMS:PHIA) Is Making Moderate Use Of Debt
Sep 17Shareholder Returns
| PHIA | NL Medical Equipment | NL Market | |
|---|---|---|---|
| 7D | 0.7% | -1.3% | -6.3% |
| 1Y | 41.8% | 14.7% | 14.8% |
Return vs Industry: PHIA exceeded the Dutch Medical Equipment industry which returned 14.7% over the past year.
Return vs Market: PHIA exceeded the Dutch Market which returned 14.8% over the past year.
Price Volatility
| PHIA volatility | |
|---|---|
| PHIA Average Weekly Movement | 4.8% |
| Medical Equipment Industry Average Movement | 5.4% |
| Market Average Movement | 4.2% |
| 10% most volatile stocks in NL Market | 7.5% |
| 10% least volatile stocks in NL Market | 2.4% |
Stable Share Price: PHIA has not had significant price volatility in the past 3 months.
Volatility Over Time: PHIA's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1891 | 68,701 | Roy Jakobs | www.philips.com |
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Koninklijke Philips N.V. Fundamentals Summary
| PHIA fundamental statistics | |
|---|---|
| Market cap | €25.44b |
| Earnings (TTM) | -€555.00m |
| Revenue (TTM) | €18.13b |
1.4x
P/S Ratio-45.8x
P/E RatioIs PHIA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PHIA income statement (TTM) | |
|---|---|
| Revenue | €18.13b |
| Cost of Revenue | €10.60b |
| Gross Profit | €7.54b |
| Other Expenses | €8.09b |
| Earnings | -€555.00m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Oct 28, 2024
| Earnings per share (EPS) | -0.59 |
| Gross Margin | 41.56% |
| Net Profit Margin | -3.06% |
| Debt/Equity Ratio | 69.4% |
How did PHIA perform over the long term?
See historical performance and comparison